Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range

Jaspal Taggar, Gregory Lip

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is a growing epidemic in the developed world that has attracted much attention due to the associated risk of stroke and thromboembolism. This article discusses the application of oral anticoagulation (OAC) therapy with vitamin K antagonists (VKA) in order to reduce these risks. The article provides an overview of OAC management and highlights the need for greater efforts to increase time within therapeutic range.
Original languageEnglish
Pages (from-to)1455-8
Number of pages4
JournalChest
Volume24
Issue number5
DOIs
Publication statusPublished - 1 May 2008

Fingerprint

Dive into the research topics of 'Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range'. Together they form a unique fingerprint.

Cite this